anyaivanova/iStock via Getty Images
Great Growth, Bound To Slow
Thermo Fisher Scientific (TMO) recently released 2Q 2021 results showing 34% revenue growth and 44% non-GAAP EPS growth over 2Q 2020. This strong growth was largely due to non-COVID revenue…
Thermo Fisher – Time To Look Past Covid
Share this article
More News
Morgan Stanley files for bank charter to custody crypto – DL News
February 28, 2026
How will a US-Iran war impact Bitcoin?
February 28, 2026
Crypto hacks drop to $37.7M, lowest since March 2025
February 28, 2026
Crypto treasury companies likely to consolidate in 2026: Crypto exec
February 28, 2026
